[1]ZHANG L, JIA X, FENG Y, et al.Plasma membrane proteome analysis of the early effect of alcohol on liver:implications for alcoholic liver disease[J].Acta Biochim Biophys Sin (Shanghai) , 2011, 43 (1) :19-29.
|
[2]JIA X, YIN L, FENG Y, et al.A dynamic plasma membrane proteome analysis of alcohol-induced liver cirrhosis[J].Proteome Sci, 2012, 2012, 10 (1) :39.
|
[3]AROOR AR, LOWERY RJ, RESTREPO RJ, et al.A Proteomic analysis of liver after ethanol binge in chronically ethanol treated rats[J].Proteome Sci, 2012, 10 (1) :29.
|
[4]COHEN JI, NAGY LE.Pathogenesis of alcoholic liver disease:interactions between parenchymal and non-parenchymal cells[J].J Dig Dis, 2011, 12 (1) :3-9.
|
[5]ZHANG LJ, WANG XE, PENG X, et al.Proteomic analysis of low-abundant integral plasma membrane proteins based on gels[J].Cell Mol Life Sci, 2006, 63 (15) :1790-1804.
|
[6]FRIEDMAN SL.Evolving challenges in hepatic fibrosis[J].Nat Rev Gastroenterol Hepatol, 2010, 7 (8) :425-436.
|
[7]YE LH, WANG CK, YANG L, et al.Effects of Ruangan Huajian granule on hepatic expression ofα-SMA, TGFβ1, and COL-Ⅰin C57 mice with experimental hepatic fibrosis[J].J Clin Hepatol, 2012, 28 (9) :685-688. (in Chinese) 叶立红, 王翀奎, 杨莉, 等.软肝化坚颗粒对肝纤维化模型C57小鼠肝组织α-SMA、TGFβ1表达和I型胶原水平的影响[J].临床肝胆病杂志, 2012, 28 (9) :685-688.
|
[8]FRIEDMAN SL.Hepatic stellate cells:protean, multifunctional, and enigmatic cells of the liver[J].Physiol Rev, 2008, 88 (1) :125-172.
|
[9]LEWIS W, DALAKAS MC.Mitochondrial toxicity of antiviral drugs[J].Nat Med, 1995, 1 (5) :417-422.
|
[10]PARZEFALL W, KAINZBAUER E, QIN HM, et al.Response of isolated hepatocytes from carcinogen sensitive (C3H) and insensitive (C57BL) mice to signals inducing replication or apoptosis[J].Arch Toxicol, 2002, 76 (12) :699-706.
|
[11]ZHANG LJ, JIA XF, TENG ZL, et al.Biomarkers of liver cancer related to hepatitis B virus selected by proteomics[J].J Clin Hepatol, 2011, 27 (5) :553-557. (in Chinese) 张丽军, 贾小芳, 滕珍林, 等.基于蛋白质组学筛选获得的乙型肝炎病毒相关肝癌诊断标志物的研究进展[J].临床肝胆病杂志, 2011, 27 (5) :553-557.
|
[12]ZHANG L, JIA X, ZHANG X, et al.Alpha-1 antitrypsin variants in plasma from HIV-infected patients revealed by proteomic and glycoproteomic analysis[J].Electrophoresis, 2010, 31 (20) :3437-3445.
|
[13]ZHANG L, JIA X, ZHANG X, et al.Proteomic analysis of PBMCs:characterization of potential HIV-associated proteins[J].Proteome Sci, 2010, 8:12.
|
[14]ZHANG L, PENG X, ZHANG Z, et al.Subcellular proteome analysis unraveled annexin A2 related to immune liver fibrosis[J].J Cell Biochem, 2010, 110 (1) :219-228.
|
[15]ZHAO Q, FENG Y, JIA X, et al.Proteome analysis of hepatic non-parenchymal cells of immune liver fibrosis rats[J].Sci China Life Sci, 2014, 57 (3) :303-314.
|
[16]MOLLEKEN C, SITEK B, HENKEL C, et al.Detection of novel biomarkers of liver cirrhosis by proteomic analysis[J].Hepatology, 2009, 49 (4) :1257-1266.
|
[17]CHEUNG KJ, TILLEMAN K, DEFORCE D, et al.Proteomics in liver fibrosis is more than meets the eye[J].Eur J Gastroenterol Hepatol, 2008, 20 (5) :450-464.
|
[18]GALLIGAN JJ, SMATHERS RL, Shearn CT, et al.Oxidative stress and the ER stress response in a murine model for earlystage alcoholic liver disease[J].J Toxicol, 2012, 2012:207594.
|
[19]WEBB C, TWEDT D.Oxidative stress and liver disease[J].Vet Clin North Am Small Anim Pract, 2008, 38 (1) :125-135.
|
[20]ZHU R, WANG Y, ZHANG L, et al.Oxidative stress and liver disease[J].Hepatol Res, 2008, 42 (8) :741-749.
|
1. | 张连峰,杨丽敏. 胸腺肽肠溶片联合聚乙二醇干扰素对慢性肝炎患者的治疗效果及其相关指标的影响. 中国当代医药. 2020(04): 50-52 . ![]() | |
2. | 王雪云,孙敏,赵巧云,李红军,王先芝,郑玉山,边城. 聚乙二醇干扰素联合富马酸替诺福韦治疗慢性乙型肝炎的疗效观察. 医学信息. 2020(04): 144-146 . ![]() | |
3. | 刘征. 恩替卡韦联合α-干扰素对慢性乙型肝炎患者血清ALT复常率的影响. 淮海医药. 2020(02): 181-183 . ![]() | |
4. | 李淑,彭雁忠,胡国信,齐明华,武敬. 聚乙二醇干扰素治疗低水平HBsAg慢性乙肝患者疗效. 中国热带医学. 2020(07): 676-681 . ![]() | |
5. | 嵇玮嘉,颜学兵. 聚乙二醇干扰素α-2a与聚乙二醇干扰素α-2b治疗慢性乙型肝炎的效果及安全性比较. 临床肝胆病杂志. 2019(02): 309-314 . ![]() | |
6. | 吴明杰. 聚乙二醇干扰素α-2b对慢性乙型肝炎的作用分析. 中国继续医学教育. 2019(12): 142-144 . ![]() | |
7. | 张珊,王艺璇,孙静,朱琳,王凤水,邢卉春. 干扰素联合抗病毒治疗对提高核苷(酸)类药物经治慢性乙型肝炎患者表面抗原阴转率的影响. 中华实验和临床感染病杂志(电子版). 2019(04): 273-280 . ![]() | |
8. | 郭志勇,贺文娟,裴军芳. 聚乙二醇干扰素α-2a注射液联合替诺福韦酯治疗e抗原阳性慢性乙型肝炎疗效分析. 中国药物与临床. 2019(22): 3944-3946 . ![]() |